Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 146

Sort by

Sort Order Select

Journal Articles

Neuropathic Pain Is Associated with Poor Health-Related Quality of Life in Adolescents with Sickle Cell Disease

Marisa Roman, BA, Janelle Highland, MA, MPP, Dawn Retherford, Amy Pan, PhD, Julie Panepinto, MDMSPH, Amanda M. Brandow, DO, MS

Blood (2019) 134 (Supplement_1): 417.

https://doi.org/10.1182/blood-2019-127626

Published: 2019

Journal Articles

Home-Based Assessment of Patient Reported Outcome Measures Using a Smartphone App Platform: A Feasibility Study

Sherif M. Badawy, MD, Leonardo Barrera, MPH, Graham Zolkowski, BS, Zeinab Alward, MBChB, MPH

Blood (2019) 134 (Supplement_1): 420.

https://doi.org/10.1182/blood-2019-131334

Published: 2019

Journal Articles

Home or Away from Home: A Multi-Institution Study Comparing Medical Outcomes, Patient Perspectives, and Health-Related Quality of Life for Outpatient Versus Inpatient Management after Chemotherapy for Pediatric Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 379.

https://doi.org/10.1182/blood-2019-131761

Published: 2019

Journal Articles

Peripheral Blood Cytopenia and Subsequent Risk of Cardiovascular Disease and Mortality

Radhika Gangaraju, MD, Insu Koh, PhD, Marguerite R. Irvin, PhD, Leslie A. Lange, PhD, Damon E. Houghton, MDMS, Diego A Herrera, MD, Monika Safford, MD, Mary Cushman, MD, Smita Bhatia, MDMPH, Neil A. Zakai, MDMSc

Blood (2019) 134 (Supplement_1): 5002.

https://doi.org/10.1182/blood-2019-125956

Published: 2019

Journal Articles

Time to Second Treatment As a Proxy for Overall Survival in CLL/SLL: Identifying Risk Factors to Help Guide Treatment Selection

Kurt S. Bantilan, MPH, Jacob D. Soumerai, MD, Lindsey E. Roeker, MD, Anthony R. Mato, MDMSCE, Andrew D. Zelenetz, MD PhD

Blood (2019) 134 (Supplement_1): 4299.

https://doi.org/10.1182/blood-2019-130109

Published: 2019

Journal Articles

Identification of a Specific Immunophenotype Associated with a Consistent Pattern of Genetic Mutations Including Srsf 2 and Gene Expression Profile in MDS

Wolfgang Kern, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Constance Baer, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 4255.

https://doi.org/10.1182/blood-2019-130095

Published: 2019

Journal Articles

Analysis of Falls in Older Adults with Multiple Myeloma Undergoing First-Line Therapy

Kelly L. Schoenbeck, MD, Tanya M. Wildes, MD, Mark A. Fiala, BS

Blood (2019) 134 (Supplement_1): 5886.

https://doi.org/10.1182/blood-2019-129611

Published: 2019

Journal Articles

Comprehensive Analysis of 22 Cases with Blastic Plasmacytoid Dendritic Cell Neoplasm Reveals Mutations in DNA Repair Genes and Two Distinct Subgroups Defined By Differential Gene Expression with Prognostic Impact

Anna Stengel, PhD, Wencke Walter, PhD, Constance Baer, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 1234.

https://doi.org/10.1182/blood-2019-125645

Published: 2019

Journal Articles

Lenalidomide Plus Bortezomib and Dexamethasone in the Treatment of Newly Diagnosed Multiple Myeloma: Results from a Canadian Cost-Effectiveness Analysis

Michael Sebag, MD PhD, Julie Stakiw, MD, Thomas J. Stephens, Amie Padhiar, Tony Kim, Jane Shum, Sujith Dhanasiri, Suzanne Trudel, MD

Blood (2019) 134 (Supplement_1): 70.

https://doi.org/10.1182/blood-2019-123636

Published: 2019

Journal Articles

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Michelle A. Roesler, BS, Amy Linabery, PhD MS, Michaela Richardson, MPH, Adina Cioc, MD, Betsy A Hirsch, PhD, Phuong L. Nguyen, MD, Erica D. Warlick, MD, Jenny Poynter, PhD

Blood (2019) 134 (Supplement_1): 3014.

https://doi.org/10.1182/blood-2019-130940

Published: 2019

Journal Articles

Impact of Sickle Cell Disease Symptoms on Patients' Daily Lives: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)

Ifeyinwa (ify) Osunkwo, MD MPH, Biree Andemariam, MD, Baba PD Inusa, MD, Fuad El-Rassi, Beverly Francis-Gibson, Alecia C. Nero, MD, Caterina P. Minniti, MD, Cassandra Trimnell, BA, Miguel R. Abboud, MD, Jean-Benoît Arlet, Raffaella Colombatti, Mariane de Montalembert, MD PhD, Suman Jain, Wasil Jastaniah, MBBS, FRCPC, Erfan Nur, MD PhD, Laurie DeBonnett, MD, John James, MSc

Blood (2019) 134 (Supplement_1): 2297.

https://doi.org/10.1182/blood-2019-124762

Published: 2019

Journal Articles

Lactate Dehydrogenase to Carboxyhemoglobin Ratio As a Biomarker of Heme Release to Heme Processing Is Associated with Higher Tricuspid Regurgitant Jet Velocity and Early Death in Sickle Cell Disease

Annelies J. Van Vuren, MD, Laurel Mendelsohn, BS, Richard van Wijk, PhD, Caterina P. Minniti, MD, John Baird, MD, Gregory J Kato, MD, Eduard J. van Beers, MD PhD

Blood (2019) 134 (Supplement_1): 2274.

https://doi.org/10.1182/blood-2019-124048

Published: 2019

Journal Articles

Prevalence of Venous Thromboembolism in Ambulatory and Non-Ambulatory Patients with Cerebral Palsy

Michael Daunov, DO, Justin Rondinelli, MD, Sanjay P Ahuja, MD, Nathan Richard Stehouwer, MD

Blood (2019) 134 (Supplement_1): 2428.

https://doi.org/10.1182/blood-2019-130622

Published: 2019

Journal Articles

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

Sonja Seliger, Verena Geirhos, Torsten Haferlach, MD, Wolfgang Kern, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Constance Baer, PhD, Anna Stengel, PhD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 1774.

https://doi.org/10.1182/blood-2019-124704

Published: 2019

Journal Articles

First Line Treatment with Venetoclax and Ibrutinib Induction Followed By Obinutuzumab Intensification Exclusively in CLL/SLL Patients Not in Complete Remission and/or with Detectable Bone Marrow Minimal Residual Disease (NEXT STEP trial)

Sabina Kersting, MD PhD, Mark-David Levin, MD PhD, Carsten Utoft Niemann, MD PhD, Yvette Norden, PhD, Arnon P. Kater, MD PhD

Blood (2019) 134 (Supplement_1): 1753.

https://doi.org/10.1182/blood-2019-124550

Published: 2019

Journal Articles

US Optum Database Study in Polycythemia Vera Patients: Thromboembolic Events (TEs) with Hydroxyurea (HU) Vs Ruxolitinib Switch Therapy and Machine-Learning Model to Predict Incidence of Tes and HU Failure

Srdan Verstovsek, MD PhD, Valerio De Stefano, MD, Florian H. Heidel, MD, Mike Zuurman, PhD, Michael Zaiac, MD, Erwan Bigan, PhD, Michael Ruhl, PhD, Christoph Meier, PhD, Magali Beffy, PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2019) 134 (Supplement_1): 1659.

https://doi.org/10.1182/blood-2019-126410

Published: 2019

Journal Articles

National Emergency Cards for Sickle Cell Disease: A Survey on Usefulness from the Patient Perspective

Aisha Aiko Bruce, MD, Lauren Bolster, MD, Catherine Corriveau-Bourque, MD, Michelle Dang, Bsc, Ghazi S. Alotaibi, Maria McGrath, RN, Mary Anne Venner, MSN, NP, Hatoon M. Ezzat, MBBS, FRCP

Blood (2019) 134 (Supplement_1): 2171.

https://doi.org/10.1182/blood-2019-124467

Published: 2019

Journal Articles

The Effect of "Pathway" to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis

Michelle Neier, MD, Michele P. Lambert, MD, Rachael F. Grace, MD, Kerry Hege, MD, Stephanie Chiu, MPH, Julianne Thompson, Robert J Klaassen, MD FRCPC

Blood (2019) 134 (Supplement_1): 2174.

https://doi.org/10.1182/blood-2019-125686

Published: 2019

Journal Articles

A Network Meta-Analysis (NMA) to Evaluate Comparative Effectiveness of Frontline Treatments for Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Transplant-Ineligible (TIE)

Thierry Facon, MD, Jesús San-Miguel, Saad Z. Usmani, MD, Meletios A. Dimopoulos, MD, Shaji K. Kumar, MD, Maria-Victoria Mateos, Michele Cavo, Bart Heeg, PhD, Sophie Van Beekhuizen, MSc, Marta Pisini, MBA, Sandhya Nair, Annette Lam, BSc, MSc, Mary Slavcev, Jianming He, PhD

Blood (2019) 134 (Supplement_1): 2144.

https://doi.org/10.1182/blood-2019-123561

Published: 2019

Journal Articles

Quality of Life and Patient Reported Outcomes in Severe Chronic Neutropenia

Thomas F. Michniacki, MD, Lauren E. Merz, MDMSc, Harlan McCaffrey, MA MS, James A. Connelly, MD, Kelly J. Walkovich, MD

Blood (2019) 134 (Supplement_1): 3449.

https://doi.org/10.1182/blood-2019-126808

Published: 2019

NARROW

Neuropathic Pain Is Associated with Poor Health-Related Quality of Life in Adolescents with Sickle Cell Disease

Home-Based Assessment of Patient Reported Outcome Measures Using a Smartphone App Platform: A Feasibility Study

Home or Away from Home: A Multi-Institution Study Comparing Medical Outcomes, Patient Perspectives, and Health-Related Quality of Life for Outpatient Versus Inpatient Management after Chemotherapy for Pediatric Acute Myeloid Leukemia

Peripheral Blood Cytopenia and Subsequent Risk of Cardiovascular Disease and Mortality

Time to Second Treatment As a Proxy for Overall Survival in CLL/SLL: Identifying Risk Factors to Help Guide Treatment Selection

Identification of a Specific Immunophenotype Associated with a Consistent Pattern of Genetic Mutations Including Srsf 2 and Gene Expression Profile in MDS

Analysis of Falls in Older Adults with Multiple Myeloma Undergoing First-Line Therapy

Comprehensive Analysis of 22 Cases with Blastic Plasmacytoid Dendritic Cell Neoplasm Reveals Mutations in DNA Repair Genes and Two Distinct Subgroups Defined By Differential Gene Expression with Prognostic Impact

Lenalidomide Plus Bortezomib and Dexamethasone in the Treatment of Newly Diagnosed Multiple Myeloma: Results from a Canadian Cost-Effectiveness Analysis

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Impact of Sickle Cell Disease Symptoms on Patients' Daily Lives: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)

Lactate Dehydrogenase to Carboxyhemoglobin Ratio As a Biomarker of Heme Release to Heme Processing Is Associated with Higher Tricuspid Regurgitant Jet Velocity and Early Death in Sickle Cell Disease

Prevalence of Venous Thromboembolism in Ambulatory and Non-Ambulatory Patients with Cerebral Palsy

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

First Line Treatment with Venetoclax and Ibrutinib Induction Followed By Obinutuzumab Intensification Exclusively in CLL/SLL Patients Not in Complete Remission and/or with Detectable Bone Marrow Minimal Residual Disease (NEXT STEP trial)

US Optum Database Study in Polycythemia Vera Patients: Thromboembolic Events (TEs) with Hydroxyurea (HU) Vs Ruxolitinib Switch Therapy and Machine-Learning Model to Predict Incidence of Tes and HU Failure

National Emergency Cards for Sickle Cell Disease: A Survey on Usefulness from the Patient Perspective

The Effect of "Pathway" to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis

A Network Meta-Analysis (NMA) to Evaluate Comparative Effectiveness of Frontline Treatments for Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Transplant-Ineligible (TIE)

Quality of Life and Patient Reported Outcomes in Severe Chronic Neutropenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only